ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01453153
Recruitment Status : Completed
First Posted : October 17, 2011
Last Update Posted : February 26, 2018
Sponsor:
Information provided by (Responsible Party):
Halozyme Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2014
  Actual Study Completion Date : May 2015
  Certification/Extension First Submitted : February 22, 2018